IBRX’s 2025 Market Dance: Down -58.51% – Time to Invest?

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -58.51%. However, over the past six months, we’ve seen a weaker performance of 14.88%. The price of IBRX leaped by -12.85% over the last 30 days. And in the last five days, it has surged by 2.58%.

The stock price for ImmunityBio Inc (IBRX) currently stands at $2.78. The stock experienced a substantial increase in the last session, hitting $30.0 after starting at $2.78. The stock’s lowest price was $5.0 before closing at $2.9.

ImmunityBio Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $7.48 on 10/25/24 and the lowest value was $1.83 on 05/07/25.

52-week price history of IBRX Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. ImmunityBio Inc’s current trading price is -62.83% away from its 52-week high, while its distance from the 52-week low is 51.91%. The stock’s price range during this time has been between $1.83 and $7.48. The trading volume for the Healthcare sector company’s shares reached about 2.92 million for the day, which was lower than the average daily volume of 8.98 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

ImmunityBio Inc (IBRX) has experienced a quarterly rise of 5.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.45B and boasts a workforce of 680 employees.

ImmunityBio Inc: Analysts’ Ratings Unveiled

As of right now, 3 analysts are rating ImmunityBio Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.78, with a change in price of -1.13. Similarly, ImmunityBio Inc recorded 8,025,443 in trading volume during the last 100 days, posting a change of -28.97%.

IBRX Stock Stochastic Average

Today’s raw stochastic average for ImmunityBio Inc over the last 50 days is 48.70%.This indicates a increase from the raw stochastic average of the past 20 days, which was 36.49%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 42.06% and 39.64%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.